Glenmark Life Sciences has posted net profit of Rs. 106.87 crores for the period ended September 30, 2022 as against net profit of Rs. 108.73 crores for the period ended June 30, 2022. The posted net profit of Rs.115.20 crores for the period ended September 30, 2021.

The company has reported total income of Rs. 519.31 crores during the period ended September 30, 2022 as compared to Rs. 499.36 crores during the period ended June 30, 2022. It reported total income of Rs.563.85 crores during the period ended September 30, 2021.

Glenmark Life Sciences has reported total income of Rs.1018.682 crores during the 6 Months period ended September 30, 2022 as compared to Rs.1092.733 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit of Rs.215.61 crores for the 6 Months period ended September 30, 2022 as against net profit of Rs.216.11 crores for the 6 Months period ended September 30, 2021.